Alkermes (ALKS) releases positive results from a clinical study of a depression disorder...

|About: Alkermes plc (ALKS)|By:, SA News Editor

Alkermes (ALKS) releases positive results from a clinical study of a depression disorder treatment. The firm says ALKS 5461 significantly reduced the severity of depression in patients treated with the drug during a 7-day period.